Cargando…
Dynamics of Erythroferrone Response to Erythropoietin in Rats
Background: Erythroferrone (ERFE) is a hormone identified recently as a master regulator connecting iron homeostasis and erythropoiesis. Serum ERFE concentrations significantly increase in animals and humans with normal or impaired kidney function after receiving exogenous erythropoiesis-stimulating...
Autores principales: | Xu, Peng, Wong, Raymond S. M., Krzyzanski, Wojciech, Yan, Xiaoyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065252/ https://www.ncbi.nlm.nih.gov/pubmed/35517793 http://dx.doi.org/10.3389/fphar.2022.876573 |
Ejemplares similares
-
Dynamics of Erythropoietic Biomarkers in Response to Treatment With Erythropoietin in Belgrade Rats
por: Nguyen, Ly M., et al.
Publicado: (2018) -
Scaling Pharmacodynamics from Rats to Humans to Support Erythropoietin and Romiplostim Combination Therapy to Treat Erythropoietin-Resistant Anemia
por: Fan, Xiaoqing, et al.
Publicado: (2023) -
Erythroferrone is not required for the glucoregulatory and hematologic effects of chronic erythropoietin treatment in mice
por: Coffey, Richard, et al.
Publicado: (2018) -
A Comprehensive Analysis of the Erythropoietin-erythroferrone-hepcidin Pathway in Hereditary Hemolytic Anemias
por: van Vuren, Annelies J., et al.
Publicado: (2021) -
Marathon Run-induced Changes in the Erythropoietin-Erythroferrone-Hepcidin Axis are Iron Dependent
por: Tomczyk, Maja, et al.
Publicado: (2020)